Introduction
Chronic pelvi c pai n (C P P ) i s c ommon, a f f e cting 5 -26 .6% o f w omen (1 –4) . It h a s si gnific ant impac t o n
qual ity of li fe and hig h a ssoc iat ed c o s t s f or i ndividu al s, s oc ie ty a nd heal thc ar e pr ovide rs (5) . Ye t, C P P
is neg lec ted a n d under fund ed in both p a i n and w omen’ s hea l th re sea r c h field s.
The Tran sla tional R e sea rch in Pel vic P ain (TRi PP ) pr ojec t (ht t p s: // w ww.i mi-
pai ncare .eu / P RO JECT/TR IP P/ ) i s a colla b orati on betw ee n aca d emic s in the UK, E urope a nd the US A ,
Europea n Pha rma c ompani e s , a small -mediu m s i zed e nte r pri s e (S ME) a n d p atien t pa r tn er s. I t
focu s se s o n end om etrio si s-a s s oci at ed pai n (EA P ) and int er s ti tial cy s ti ti s/ bl a d der pai n s y ndr o m e
(I C/B PS ) in wo men, two co ndition s w her e CP P is highl y preval e nt and for w hich c urr e n t tre atmen t s
predomin an tly t arge t t he p eriph e r y (ec topic t issu e for en d omet r i o s i s and t h e bla dder f or IC / B P S )
and ar e of t e n ine ff ec tive (6) . Ou r hy po t h e s i s i s th at the p ain s y mpt o m s in th es e condi tion s ar e
gen era ted and main taine d b y mecha nisms s i mila r t o tho s e foun d in ot h er c hro nic pain c ondition s
but occ ur in combi nation with spec i fic patholog ica l le s io n s an d s y mpt o m s (8,9 ). W e bel i eve tha t
recon cep tual i s ing the se co ndition s in th e co nt e xt of t he multi sys tem dysfun cti o n know n for othe r
ch r oni c pai n cond it i o ns r ath er th an a s so lel y end-o rga n pat hologi e s ha s t h e pot en tial to imp r ov e o u r
under st anding of the con d ition s , all ow us t o id enti fy mea ning ful s ub group s o f pa t i e nt s, devel o p
bett er pre clin ical m odel s an d thu s ultim a t e ly f ac ilita te r e s e arch and drug d evelo p ment in thi s fie ld .
The pr e s e nt p rojec t t a ke s a d eep -ph eno typing approach , combin ing c linic al, bi ol o gica l, physiol og ica l
and ps y cholog ica l da ta, to i mprove ou r u nde rst anding of CP P i n women .
Aims/Objectives
The primary obje ctive i s to e st a b lish p e rturba tion s i n th e function of pain -rel ev an t
sys t e m s/mecha ni sm s th at a r e spec i fic t o E A P an d IC /B PS, an d tho se t h a t ov erl ap both c ondi tion s
(EAB P) an d C PP mo re ge n erally. Th e sec ond ary objec tive s are to: a) e stabli s h bi o marker pro fil es tha t
are speci fic to E AP a nd I C/BPS a nd tho se tha t overla p bo t h c ondi tion s and CP P more gener al ly; b )
d e t e r m i n e w h e t h e r w o m e n w i t h p e l v i c p a i n c a n b e s t r a t i f i e d b a s e d o n c l i n i c a l d a t a , t h e f u n c t i o n o f
pai n-rel evan t s y stem s and t heir b iom arker pr ofil e and ide nti fy any key pathw ays / p roc e sse s
underly ing pain in the se s ubg r o up s t h a t may point t o nove l th erap eutic t arg et s; a nd c ) ex plor e
whe t h er any subgro up s ide n t i f i ed during the study r e l ate to r es pon s e t o previou s trea tmen t.
Study Design
TRiP P is an ob s e rv ation al coho rt st ud y bei ng c on ducted in pha s e s an d inc lu des f ive group s o f
partic ipan t s : EAP : endome trio si s-a ssocia t e d pain; EA BP : en dom e t rio si s -a ssoci at e d and bladde r p a in ;
BPS : in te r st i tia l c ys titi s/bladd e r p ain syndrome; P P: p elvi c pain with n o end o metrio si s o r bla dd e r
symptom s; and C ON: c ont r ols with no p e lvic pain or bladde r symptom s; (Figu re 1). T he study build s
upon two ex i s ting e n domet rio s i s cohor t s tu die s in O x f or d a n d Bo st on (End O X : A study to id en t i fy
pos s i bl e bioma rk ers in w omen with en d ometr i o s i s , Oxf ord RE C r ef 09/H 06 04 / 5 8 ; Bo s t on Cent er fo r
Endom etr io si s ( BC E ): A C ro ss-In sti t uti on a l Biorep osi tor y a nd D a ta ba se , IRB - P000 042 67). G i ven th a t
neithe r coh ort has a spec i fic focu s on bladder pain we pl ann ed to rec ru it ad d itional wome n w it h
I C/ B P S fr o m I nst i t ut o de B i o lo gi a M o le cul a r e C elu l a r ( IB M C) P o rt o . O ve ra l l we a im e d t o id e nt i f y 800
wom en with compl ete b a se line qu e stio nnaire s a nd avai l able bio sp ec imen s ( c ol lec ted acc or ding t o
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Endom etr io si s Ph enome a nd Biob ank ing Harmoni sa tion Projec t ( E PH e ct ) re com men dation s) (10, 11 )
who meet our inc lu sion /exc lu s i on cri teri a to fo rm the TRi PP c oho rt.
From thi s coh ort w e aimed t o r e c ruit 20 0 pa r t ic ipant s t o u nde rgo p sych ophy siol ogic al te s ting a nd o f
the se , 100 who w ould a ls o und ergo a ne uroimagi ng scan .
Dat a from e ach study ph as e w ill be a nal ys e d sep ara tely ini tial ly, w it h sub s e quent multi -moda l
a n al y s is i nt e g r at i n g t h e d iff e re n t d at ase ts .
Dat a coll ecti on i s c onduct ed at t h e Uni ve r si ty of Oxford , Bo ston Chil d r e n s H o spital , Br i g h am and
Women's H o spit al an d I BMC Po rto . Th e study c ommenc ed in April 20 18 a nd is s t i ll ongoi ng , w it h
TRiP P s pe ci fic recr uitmen t ha ving commen ced i n Sep tembe r 2 019 af ter a l l regula t ory approval s w e r e
ga ined. All re crui tment i s now comple t e .
Figu re 1. T RiPP Stud y De si gn. P hase I in Oxford and Boston c o nducte d p rior to T Ri P P c omm enc emen t. Pa rti cipants from
Oxford an d Bo s ton s electe d ba se d o n inc lu s i o n cr it eria from a v a i labl e coho rts (E n d OX an d B C E ). P h as e I recruitment a t
Po rto (I BMC) c o m menced with stud y. P h a s e II in c l ud e d a d d it ional question naire s c o m p lete d o n li ne or on paper fo r all site s.
Ph ase II I c arri e d o u t by tr ain e d res e a rc h e r s a t eac h site . Ph ase I V carried ou t at Oxford b y tra i ned re search ers.
Study P opulation and sample s ize
Par tic ipant s f o r mi ng th e TRi P P coh ort w e re se lec ted acc ordi ng to th e fol l owing criteria :
All g r ou p s :
• Aged 18 – 50 y ea r s ( ac knowl edging som e wi ll have be e n younge r whe n the y firs t
co nt ribu ted da ta t o END O x / B CE )
• Not pre gnant , l acta ting or planni ng preg nan cy d ur i ng the c our se o f the s tudy
EAP:
• sur g ica l diag n os i s o f e nd omet r i o s i s;
• at le a st one pelv ic pa in scor e of > 4/ 10 on numeric al ra ting s sca l es (N RS )
• no urina r y s y mptom s ( e .g. urge , fre quen cy )
• pai n not pe rcei ved a s a r i sing fr om t h e bl adde r.
Additional Questionnaires
P hy s iol ogi c al T esti ng
fMRI ( onl y c on ducted a t Ox for d )
Addi tio nal Q u estio nnaires
EAP , EABP , BPS, PP , Con
( sel ec te d f r om EndO X a n d BCE)
BPS
( r ecr u ited a t IBMC)
Ba s eli ne Q u esti onn a i r es, Blo od,
Saliva , U rine (p r eviou sly
co l l e c t e d )
Ph
ase II
Ph
ase I
I
I
Ph
ase IV
Ph
ase I
Ph
ase I
and II
Base lin e Q u estio nnaires + B l ood ,
S a li v a , U r in e
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
EABP:
• sur g ica l diag n os i s o f e nd omet r i o s i s;
• at le a st one pelv ic pa in scor e of > 4/ 10 on NRS
• urinary s y mp t om s
• pai n percei ved a s a r i sing from t he bla dd e r a nd f rom oth er ar ea ( s) o f th e pel vis .
BPS :
• no hi story of e ndome trio s i s ;
• at le a st one pelv ic pa in scor e of > 4/ 10 on NRS
• urinary s y mp t om s
• p a in p e r c e iv e d as ar is i n g f r o m t h e b l ad der .
PP:
• no hi story of e ndome trio s i s ;
• at le a st one pelv ic pa in scor e of > 4/ 10 on NRS
• no urina r y s y mptom s
• pai n not pe rcei ved a s a r i sing fr om t h e bl adde r.
CON:
• no hi story of e ndome trio s i s ;
• no pe lvic pain, all sco r e s <3 /10 on NRS
• no urina r y s y mptom s
Reg r e tfull y, du e to the CO VI D-19 p ande mi c rec r uitme n t of n e w IC /B PS pa rtic ipa nts h ad to b e ha lt e d
in March 2 020 and ther ef ore t he m ajori ty of t ho s e in t he B PS g roup w er e al so i denti fied fr om th e
ex is ting s tudi es . Th e full TRi PP c oho rt t here for e comp ris e s 7 86 women div ide d into th e f i ve study
groups . Par t i cipa nts who agr ee d to p art icip ate in T RiP P s pe ci fic p ha se s o f the s tudy coul d c hoo s e
whi ch part( s ) o f the s tudy th ey w ished to be i nvolv ed in as l ong as th ey are ab le to give i nfor m e d
co ns e nt for t he i r pa rtic ipati on. Fo r phas e I V ( fMRI ) they n e ed to me et a p propri at e
inc lusion / e xcl u s io n crit eria rega r d i ng MRI ma gnet sa fe ty.
T h e s a m p l e s i z e o f t h e o m i c s b i o m a r k e r d i s c o v e r y a n a l y s e s i n t h e m a i n c o h o r t w a s c h o s e n t o
m a x i m i s e p o w e r o f d i s c o v e r y w i t h i n t h e m o s t e a s i l y b a c k t r a n s l a t a b le b i o s p e c i m e n ( b l o o d ) , a l l o w i n g
sel ec t i on of p romi sing, r ob u st signa l s tha t can be t arge ted f o r f u rther an aly si s a s pe r ex isting
litera tur e (12 ). T he s amp le siz e f o r the sub sequ ent ph a se s o f t h e st udy were dete rmined on th e
basi s o f pr eviou s li t e r a t u re, h owev er , a p ragm atic de ci sion a b out clo sing rec ruitm ent wa s req uired i n
the li ght o f th e CO V ID -1 9 pand em ic to a ll ow time to comp le te all an aly se s.
Our f u ll co hort c ompri s e s 7 86 p artici p ant s , with 158 h avin g com plete d add i t i onal que s tionn a ire s a n d
85 the physi ologi cal t e sting parad igm. f M RI dat a c ollec ti on is o ngoi ng.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Table 1. TRiPP Study Measures and Outcomes.
Outcome Measures
Baseline Questionnaires
All women id enti fied fr om E N D Ox and BC E had al r e ady com plete d the ba se lin e que stion naire (10)
and the se da ta ha ve bee n harmoni se d in a RE D C a p data ba se . Th is que s ti onna ire pro vide s a
comprehe n s iv e pro file o f th e pa r tic ipa nt s by inc luding gynae colog ical , obstet ric and medic al hi s t ory ;
detail ed a sse s s men t of t heir p elv ic pai n now and prev iou s l y; and imp ortant d emog r a phic v ariable s .
P ar ticipa nts rec r ui ted a t IB MC co mple te d the ba sel ine and additio na l que s t i onna ire s once con se nt e d
a n d t h e s e d a t a w e r e e n t e r e d i n t h e d a t a b a s e . W o m e n r e c r u i t e d t o p h a s e I I f r o m O x f o r d a n d B C H
compl eted addit ional q u e s tio nna ir e s on pap er or di rectly in to the d a t a b a s e . D a t a e n t e r e d b y ha n d
fr om p aper ve rsion s wa s do ubl e ent ered to r educ e err or f o r a minimum o f ~20% of t h e qu e stio ns fo r
eac h pa rtic ipant . All qu e st i on nair es w e re a vaila ble in Engli s h and P or tugue se . F or the P or tugue s e
versio n, vali da ted tran sla tion s we re u s e d where av ailabl e, ot h e r w ise forwa r d a n d b ack t ran sla tio n
was u sed .
Additional Questionnaire Development
The ques tionn ai r e s for P h a se I I of t h e st udy w ere s el ecte d by the T RiP P con so rti um with addi t i ona l
input from membe rs o f IMI -P ain C a r e (E PZ, RDT) . T h ey w ere cho se n t o a ll ow a wide und er s t an ding o f
C PP in the c ont ext o f w hat is known abo ut ot her chronic p ain condi tion s (e .g.m o od, ca ta s tr ophizing ,
s le ep di s tur ba nce s) (13–15 ) . Some o f t h e se do main s h ave b een a s s e ssed prev iou s ly in endom etri os i s
and/o r I C/BPS (e.g . ga st r oin t e stin al sy mptoms) b ut not in combin a t i o n w ith the va rie ty o f o the r
m e a s ur es co l l e c t ed h er e , w h ils t ot h er a r e as h a v e n ot b ee n as se ss ed b ef o r e ( e. g . a d et ai l ed
charac te ri s a t i o n of fl are s i n endome trio s is ) . T able 2 i llus t ra te s the domai n s be ing as s e ssed and t o ol s
that a re u sed for ph a se I I.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Physiologi cal a s ses s ments
Very li t tle i s k nown ab ou t th e neu rophy s iology of women with C PP . T he Mul tidi s cipl inary Appro ac h
to t h e S tudy of C h r oni c Pe lv ic Pain (MA PP ) N e t w ork ha s und ertak en many of t hes e te s t s in tho s e
wi t h Ur o logic Ch ronic P elvic P ain Synd rome (an ove r a r c hing term that incl u de s I C/ BPS ), howe ve r
their c ohor ts c ompri se bo th m en a n d wom en ( ht tp s :/ / w ww .mappne two r k .o rg
). Dat a from thi s
group and o ther s l oo king at wome n on l y do s uppo rt the id ea th at the se c o ndit ions are simila r t o
other chr onic pain condition s (16,1 7 ); ho wev er, to dat e thi s ha s not been c ompre hen sively as s e s s e d
by c ombini ng multiple a ss es s m en ts in a d ee ply p heno typed c oh ort and in c ombination w i t h
endom e t rio si s. Th e par adig m fo r TRiP P wa s de sign ed w ith i npu t from pai n re s e archer s w ithi n th e
T R i P P c o n s o r t i u m ( L A N , Q A , S M , C S , K V ) a n d I M I -P a i n C a r e p r o j e c t ( E P Z , R D T ) . W e a i m t o a s s e s s a l l
relev an t sy st ems whi l s t keepi ng th e paradi gm a n a cce pt a bl e length and avoid ing invasiv e
proce dure s . Pa t i en t par t n e rs ( JB, LH, JM ) were k ey to d e signin g an ac ce p t a bl e pa radi gm. In ord er t o
ens ure r epro ducib ility be tw een the c e ntr e s , a ll re se arch er s involv ed in th e p hysiologic al d a ta
co llec t io n a tten d ed a coordina t e d t raini n g s e ss ion in H e idelb erg, Ge rmany i n Septemb er 2019 a nd
sub s e quen t po st -C O V ID vir tual r e f r e she r se s s io ns. The compo nen t s of the pa r adig m a r e lis ted i n
Tab le 2. A q ue st i onnair e a s se ssing s t a t e m ea sures con s ide r ed i mp orta nt c ovaria te s for th e a n alysi s
of t he se p hysiol ogi cal da ta i s c omple ted prior to e ach e xperim enta l se s s i on (“How are yo u toda y? ”
que stionn ai r e ).
Omics
EDTA pla sma f rom bi ob anks ( stor ed for a max imum o f 8 y e ar s ) and new ly recr uited pati en ts w a s
use d to ob ta in gen o t y pe s of pa rtici pa nts a nd qua nti fy the rel a tive abunda n c e of p r o tein s a n d
metabo li te s. 1 82 p rote in s w e re mea sur e d u sing Oli nk’ s pr oxi mity exten si on a ssa y i nflamma tion a n d
neurolog y pa nel s (18) and ~1200 met a bo lite s w e r e qua n t i fi ed u s in g ul tr a -hi gh per for ma nc e liqu i d
ch r oma t o gr aphy-tande m ma s s spec trom etry run i n four di ff er ent mode s by M e t a bolon.
fMRI
Neuroim agi ng wi ll be used t o furthe r un de rsta nd th e c ent ral proc e s s e s unde rlyin g obse rvation s fro m
the phy siolog ica l t e s ting an d e xplore whe t h e r MR I marke rs ob s e r v ed in other c hronic p a i n
co ndition s a r e pr e sen t in C PP . Th e s c an nin g pr o toc ol incl u de s s tr uc t ur a l and fu nctiona l s eque nce s
(s ee Ta bl e 1 ) and is a ligned t o the fMRI pr otoc ol of th e Bio P ain su bprojec t o f IM I -P ai nC are . P unc ta t e
st i muli will b e u sed for t he “ pai n ta sk” a s they h av e be en pr evi ou s ly demon s t r ated to give robu s t
a c t i v a t i o n o f k e y p a i n -r e l a t e d a r e a s i n h y p e r a l g e s i c s t a t e s ( b o t h e x p e r i m e n t a l ( 1 9 – 2 1 ) a n d c l i n i c a l
(22) ) an d in w omen wi t h endom etri o si s -as socia ted p ain w ithou t hype r a lge si a (KV unp ublish ed da ta) .
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Domain Tool Study Componen t S t u d y
Phase
Pa i n:
• Clinical
his tor y of
pe l v i c pai n
EPHect c linica l c ovari a t es q u e st io n na ire
(2 3 )
B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
I
II
• Int e n sit y NRS B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Ho w a re y o u t o d a y?
I
II
III
• Nat ure i) pai nD E T E C T (2 4)
ii) Sh o r t-f o r m McGill Pa in Qu est io nna i r e 2
( S F M PQ 2) (25 )
P a in C ha r a c te r i sti cs I I
• Loc a ti on i) Fibr omy a l gi a s urve y s ca l e (26)
ii) B od y m ap
Oth e r s y mpt o ms a nd
ex pe r i e nc es
Ho w a re y o u t o d a y?
II
III
• Co m or bi d
pa i n
c o nd i t i ons
i) D i a gn ose s give n
ii) C o mplex m e d ical s ym p t oms in vent o ry
(2 7 )
iii ) T MD -pai n s cree n in g t oo l ( 2 8)
B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Oth e r s y mpt o ms a nd
ex pe r i e nc es
I
II
II
Gastro in te s tina l
sy mpt om s
i ) E P He c t c l in i ca l c ov a r ia t e s qu e st ion na i re
(2 3 )
ii) T he Gas troi nt e s ti n al S ymp t om R atin g
Scal e (29)
B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Oth e r s y mpt o ms a nd
ex pe r i e nc es
I
II
Mo od Hos pi ta l A nxiet y an d D e pre ss io n S cale
(HA D S) ( 3 0)
Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
State anx i e ty i n v e nt or y ( 3 1 ) Ho w a re y o u t o d a y? III
Pa i n C o g n i ti on s Pa i n C at astr o ph i s in g Scale ( 3 2) B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Ho w a re y o u t o d a y
I
II
III
Pe r so n a lit y Pe r so n a lit y I n v e n t ory ( 3 3 ) Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
Soma tos ens ory
proces si n g
i) Q ST ( 34) o n t he l ower abd o m e n (tes t
site) an d d ors um o f t he f oo t (c on trol s ite)
ii) f M RI wi t h p u nctat e s timu li o n t he t hig h
P hy si o log i ca l te s ti n g
fM RI
III
IV
Visceral s ens iti vit y Blad de r Sens iti vit y pa ra dig m (3 5) P h ys io l o g ic a l t est ing III
A u t o no m i c ne r v ou s
s y st em fun c t ion
i) heart ra t e mon it oring bef ore a n d aft er
p a in s ti m u li
P h ys io l o g ic a l t est ing III
HP A a x i s f u ncti o n i) 2 4 hour c ortis ol p r o fil e ( s a li va)
ii) c ort is ol bef o re an d a fter p a i n s ti m u li
(saliv a)
P h ys io l o g ic a l t est ing III
En d og enou s pa in
m o du la t ion
Co ndit ion ed pain m odu la t io n paradi gm
(3 6 )
P h ys io l o g ic a l t est ing III
Fl ares i n sy mpt o ms
and tri g g ers
Ch a racterist ic s o f fl are s i n s ym pt oms an d
ass ociat ed tri g g ers ( 37)
F la r e s qu es tion na i re II
Sl ee p a nd f atig ue i) AS CQ-Me v 2 Slee p I m pa c t S h o r t For m
(3 8 )
ii) N eur o-Q OL v1 F a t ig ue ( 3 9 )
Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
M e d i c a l h i s to r y i ) E P He c t c l in i ca l c ov a r ia t e s qu e st ion na i re
ii) All e r gies
B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Oth e r s y mpt o ms a nd
ex pe r i e nc es
I
II
II
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
T r a u ma C h i ld ho od t r a um a ti c e ve nt s sc a l e (4 0 )
Rece n t tra u m at ic e v e nt s sc ale (4 0)
Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
Tre a tm ents Tre a tm ents t ri e d qu esti o n s wi th s cori ng of
ou t c om e
T rea tme nts trie d
ques ti onn aire
II
Ove r a ll h ea l t h EPHect c linica l c ovari a t es q u e st io n na ire B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
I
II
Tabl e 2 . S tudy P ar a di g m . Asses s m e n t-too ls employ ed at ea c h stud y ph ase ba se d o n t h e domains o f interest.
Data Manag e ment and Analy s is
Par tic ipant s a re only iden tifi e d by s t u dy s pe cific pa rtici pa nt numbe r i n any databa s e. Per s on a l
informa tion i s store d s e p ara tely fr om t h ese da t a ba se s and re taine d a t th e indi vidual sit es .
Phy s iol ogica l dat a was t r a n sfer red t o the Univ ers i ty of O x for d pr i or t o analy s i s .
Derived va r i abl es w ill be calc ul ate d f r o m all v alidat ed scale s and phy siologi cal te st i n g pa r a digm s
ac cording t o pu bli shed me thod olog y. Re g ular mee ting s of the pa in da ta a n d t h e omics da ta a n alysi s
groups r evie w all analy s i s pla ns b e f or e c ommen cing analy s i s and t h e overall TRi P P s tati stic al a naly si s
pla n i s main ta ined a s a live doc ument . Appropri at e stati s tical s of tware wi ll be us e d to ana ly se th e
large volume s o f d ata c olle ct ed. Omic s modell ing w ill be p e rforme d u sing b a se R, r m s and e a s y s ta t s
pac kag es, Stan or Py MC3, a nd multipl e Pytho n pac ka ge s incl uding p ingouin . Q S T da ta w ill b e
ana lys ed in MATL AB . fM RI da ta w il l be ana lys ed wi th F SL ( F MR IB’ s S of t w are Li br a r y ;
ww w.fmrib.ox .ac . uk/ f sl
) . O t h e r s t a t i s t i c a l a n a l y s i s w i l l b e c a r r i e d o u t i n S P S S . A n i n t e g r a t i o n a n a l y s i s
w i l l b e u n d e r t a k e n t o c o m b i n e a l l t h e d i f f e r e n t m o d a l i t i e s , a l l o w i n g c o m p a r i s o n s o f t h e b i o m a r k e r
profil e s b e t w e en pa tien t g roup s a nd c ontro l s and an e xplora tion o f di f fer ent p hen otypic
pre sen tati on s.
Dis c us sion
The TRi P P c o nso r ti um ben efi t s from gl oba l in terd isci pli nary co -op e r a t i on s bet wee n c linic ian s a n d
basic sci enti s ts from a w ide vari ety of bac kground s w o rking both in a c ademia an d th e
pharma ceu tic al indu s tr y , a s well a s t hre e ac tive pa tie n t orga nisa t i o ns w ho h ave been inv olved w it h
the s t udy s in ce inc ep tion. We beli e ve th at ou r novel ap p r oa ch, bot h in te rms o f dee p phen otyping
and th e u s e o f m ethod ol ogie s not u s ua ll y app lied to th ese con dition s , ha s th e p oten tial to improv e
our und er sta nding o f p el vic pa in. W e ho pe t o be a ble t o pro duce n ov el c linic ally rele van t d ata ( e.g .
an un derst anding of t h e pre vale nce a n d impac t o f bo t h w ide spre ad pai n and flar es in C P P), id e nt i fy
underly ing pa in pathwa y s a nd thu s pot e ntia l new the rap eu tic targe t s or o pportu ni t i e s to re purpo s e
trea tmen t s fr o m o the r c ondi tion s. Mo r eove r , oth er wo rk -pa ck age s w it h in the pr o ject w ill bac k-
tran s l a te ou r findi ng s to r e fin e e xis t i ng r od en t mode l s (41 ) of e ndome trio s i s a nd IC /BP S with t h e
hope o f improving the drug de vel opm en t capa biliti e s.
L i m i ta ti o n s
The u se of ex is t i ng bio re s ou rc e s , wh il st allow ing thi s projec t t o pr oceed rel ati v ely rapidl y, me an s
that th e time be twe en bio sp ecim en coll ection an d analy s i s varie d f o r ea ch par ti ci pant and re sul te d
in sampl e agi ng o f r elev ance to th e o mi cs da ta . C ommon to mo s t rec en t st udie s, t h e C OV ID -1 9
pand emic and r elat ed res tric tion s sever e ly delay ed rec r ui tme n t and da ta coll e ctio n for ph a se s I II a n d
IV. Addi t i on ally, it limit ed our ability t o re cruit a n e w IC /BP S c ohor t of ad eq ua te si z e. W hi l st w e cou l d
mitiga te a gai ns t thi s t o an ex t ent by u s ing partic ipan t s w it h in th e bio re source s who met t he B P S
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
recruitm ent cri teri a, thi s grou p is no t of t h e si z e w e ha d o rigin ally plan ned a nd the majori ty o f
partic ipan t s were id e nt i f i e d fr om gy naeco logy r a t he r tha n u rology clin ics.
D e c l ar at i o n s
Ethic s approv al and c o ns e nt t o pa r tic ipate
The s tudy ha s rec eiv ed e thic al approva l f rom York shire & T he H um b er – S ou th Y or k s h ire R e s ea r c h
Ethic s Com mi t te e (19/ Y H/0030) w ith l oc a l s i te ap proval s and i s bei ng c on duct ed in a cc or da nce w it h
the princ ipl e s of the D ec lar ation o f Hel si nk i and with relev an t regula t i on s a nd Go od Clini cal P r a ctic e.
Info rmed con s en t is ob t a ine d fr o m a ll the pa r tic ip ant s a t e a ch pha se o f t he st udy, and they w er e
inform ed tha t th e y are f re e to w ithd raw from th e study at a ny t i me.
Availa bility of data and material
Direc t ac ce s s will be gran ted to a u thor i sed rep re sen ta tive s fr om the S p on s or a n d host i n s ti tutio n fo r
monitoring a nd/or audi t of th e s tu dy to en sur e compl ianc e with r e gula tion s. All s t udy da ta wil l b e
stored fo r 10 year s a ft er t he en d of the s t udy . Once th e study an d a ll f oll o w up anal yse s ar e
co mplete de -id enti fie d d ata will be dep osi ted in a public ly a cce s si ble rep o sito ry as req ui r e d by th e
funde r s.
Fundi ng
This p rojec t ha s r ec eiv ed fu nding fr om the Inn ova t iv e Medic in es Ini tia tiv e 2 Join t Unde rtaking u nde r
grant agre e ment No [77750 0 ]. This J oin t Under taking rec eive s suppor t fr om th e European Unio n’ s
Horiz on 20 20 r e s earc h and inn ova t i o n p r og r a mme and EFP IA. F ur t he r in f ormation i s f o un d
under w ww. imi-painc a re .eu
a nd ww w.i mi .europ a.e u .
Di sclai mer: T he s ta tem ent s and opinion s pr e s e n t e d h e r e re fle ct t he a ut h o r ’ s vi ew and nei ther IM I
nor th e Europe an U nio n , EFPI A, or any Associa t e d Pa rtn ers ar e re spo ns i ble for any use tha t may b e
made of the in forma tion cont aine d ther e in.
Ack nowledge ment s
The a ut ho rs wi sh to ac know ledge Alli s o n Vitoni s and Kur t i s Ga r b utt fo r thei r work in ha r mon i s ing
datab a se s betw een Bo s ton and Oxford a nd identi fy ing pa r tic ip ant s s ui ta ble for th e TRi PP co h or t .
Consent for publication
All a utho rs read a nd appr ov ed the fina l manuscrip t.
Competing int e r e s ts
LD, LC an d MK dec lar e no c ompe ting inte re s t s.
NR: No comp e t i ng int ere s ts
LAN: No c ompe ting i nte r e s t s
QA: N o compe ting int ere st s
CMB: R e s e arch G ran t s from Baye r H e al thcare , MD N A Life Sc ienc es, Roc he Di a g nos tic s , Eur opea n
Commis sio n, NIH. Hi s empl oyer h a s rec eived c on s u lancy fe e s from M y ovan t an d Ob s E va fo r w ork
out side o f thi s pr ojec t .
JB: N o com peting int er es t s
FC: C on s ul t a nt and /or inve s tigato r fo r All erga n ( Abbvie) , A stel la s, Ba ye r, Ip se n an d Recorda ti
AWH : r epor t s grant fun ding fr om t he MRC, NIHR, CSO, Wellb e ing o f Women , Roc he D i agno s t i c s,
Astra Z enec a, Fe rring, Charl e s Wol f s on C harita ble T r u s t and S ta ndard Li fe . Hi s employe r ha s r ec eiv e d
co ns ul tan cy fe e s from Roc h e Diag no stic s, AbbVi e, Nordi c Pha r ma and F er ring , ou ts i d e th e submi tte d
work . In add iti on, A WH ha s a pat ent for a s e rum bi omarke r fo r endome t rio si s p e nding .
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
LH: no compe t i ng int ere s ts in r e la tion t o this wo rk
JM: no c ompe ting int er e st s
EMP-Z: re ceiv ed finan cial s upp o r t from G runent hal a nd Mun dipha r ma for re sea rc h ac t i vitie s and
adv is o r y and l e ctur e f ee s f rom Gr ü ne nth a l, Novar ti s and Mund iph arma . In addi tio n, s h e r ec eiv e s
scien tifi c suppo rt f rom t h e Ge r ma n Re s e arch F ounda tion (DF G), the Fe dera l M i ni s t ry of E duca t i o n
and Re s e a rch (BM BF) , the G e r ma n Fede ral Joint Commit tee (G -B A) and the In novativ e Medic in e s
Initia t iv e (I MI ) 2 Joi n t U nde rtak ing unde r g r a nt agre eme nt N o 777500. Thi s Join t Under t a king
rece ive s suppor t from the Eur opea n Uni on’ s H orizon 2020 res earc h a nd i nnovati on pr o gramme a nd
EF PIA . All mone y w ent to th e ins titu t io n E.M.P . -Z. is w orking for .
AH: Employ ee o f Ba yer AG, Germa ny.
CS: decl a r e s no compe t in g int ere s t s
IT: On the scie nti fic advi sory boa rd f o r Amgen (2017 –2019 ); h as rec eiv e d ho no r a r i a for providin g
va r i ous e ducati on al t alk s a n d worksh op s; is a c ounci l member o f th e M e dic a l Re se arch
Counc il of the Uni ted Kingdom; i s a tru s t ee o f M Q , a men tal heal th ch ari t y ; i s Pre s i de nt -e l ect o f
FE N S ; and i s invo lved w ith I nnova tive Medi cine s Initi ativ e– Pai n Ca re (Biopai n), a p an p ha rma -
ac ademia con sor tium.
RDT: Ad bo a r d f or BA Y ER, IAS P t a s k fo r c e on c hronic pain c la ss i f i ca tion
SAM: h a s be en an a dvi sory bo ard m e mber for Abb Vie and Roch e an d rec e ive s r ese arch fundi ng fr o m
the Nati onal I n s ti tut e s o f H e a lth, th e U S D e pa rtmen t o f D e fe n se, the J . Wil la rd a nd Alic e S . M a r rio t t
Fou ndati on, a nd Ab bVi e; non e are rela te d t o t h e p re s e n t e d work .
KTZ : repo r t s g r a n t fun di ng fr om E U Ho ri z on 2020 , N IH U S , W e llb eing o f Wome n, Bay er AG, Roc h e
Diagn o s tic s , E vot ec-L ab282 , M DNA L ife S c ienc es, outsid e t h e s ub mi tted work.
JN: Employ e e and s ha reh olde r of B ay er AG , German y
KV: dec lar e s re se arch fu nding from Bay e r Heal thc ar e and honor aria for c on sul ta ncy a nd ta lks a n d
as s o cia ted t rav el ex pe ns e s f r om Ba yer H ealthc a re, Grun enth al GmBH, A bbVi e an d Eli Lill y.
Author ’s c ont ributions
LD, LC, MK a nd K V d ra fted t he ma nu s c r i pt . All othe r autho r s con tribu ted to th e o rigi nal de sign o f th e
projec t and r evi ewed and e di t e d the ma nuscrip t.
Reference
s
1. E s ke nazi B , War ner ML. Epid emio logy of endome trio si s . O b ste t G y neco l Clin N ort h Am.
19 97;24(2) :235 –58.
2. Z ondervan KT, Yud kin PL , Ve s s e y M P, J en k ins o n CP, Daw e s M G, Ba r l ow DH , e t al. T he
c ommunity pr e vale nce o f chronic p elvi c pa in in w omen a nd a s s oc iat ed il lne s s be haviou r . Br J
Gen P r a ct . 2001 ;51(468 ):541 –7 .
3. Z ondervan KT, Bec ker C M, Ko ga K, M i s s mer SA, T aylor RN , Vig an ò P. E ndom etri o s i s. N at R ev
Di s Prim. 2 018;4 (1) .
4. Aha ngari A . Pr ev alenc e of c hro nic pe lvic pain among women: an upda ted r e view . Pain
Ph ysicia n . 2014;1 7(2 ):E141–7 .
5. Dani el s JP, Khan KS. Chr onic pelv ic p ain in women. Bmj. 2010 ;341.
6. S ingh S S, Gude K, P erd eaux E, Gat tr ell W T, Becke r CM. Surgic al ou tc ome s in pati e nt s w ith
e ndome trio s i s: a s y stem atic revie w. J Ob s t et Gyna ecol C anad a . 2020;4 2(7 ):881 –8.
7. Horne A W, D anie l s J , H umme lsho j L, Cox E, Coope r KG. Su rgi cal r e moval o f s up e rfi c ial
pe r i tone al end ome tr io s i s f or mana ging w omen w ith chronic pelv ic pain: tim e for a rethink?
Bjo g. 2019 ;126(12) :141 4.
8. Aziz Q , Gia mb era rdino M A, Bark e A, Kor wisi B, Ba r a now ski AP, W e sselman n U , et al. T he IAS P
c las s i fi catio n o f chro nic pain f o r I CD -11: c hronic sec onda ry visceral p ain. P a in.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
20 19;160(1) :69 –76.
9. Nic hola s M, Vlae yen JWS, Ri ef W, Ba rke A, A ziz Q , B enolie l R , et a l . The I A S P c la ssi fic atio n of
c hronic pain fo r I CD -11: c hronic p r ima r y pain . P ain. 2019;16 0 (1):28 –37.
10. Viton i s AF, Vinc e nt K, Rahmi og lu N, Fa ss bender A, L oui s GM B , H um mel s h oj L, et al. Worl d
E ndometrio s i s R e sea rc h Founda t i on End ome t rio si s Phenom e and bio ba nking har monization
proje ct: II. Cl inica l and cova r i ate p heno typ e data c oll ec tion in e ndome trio s i s r es ea rch. Fer til
S t e r i l . 2014; 102(5 ):1223– 32 .
11. Ra hmioglu N , Fa s s be nder A, Vi toni s AF, T w oroger SS , Hummel shoj L , D’Hoo ghe T M, et al .
World e nd omet r i o s i s re s earch f oun da tio n endom etrio si s phen ome and bi ob anki n g
ha r mo niz a t i on proj ect: I I I . Flui d bio speci men co llec t io n , proce s s i ng, a nd storag e in
e ndome trio s i s re s earch . Fer til Ste ril. 201 4;102 (5) :1233–43 .
12. F earnl ey LG, Inouy e M . Me tabol omic s in e pidemiol ogy: from me ta bolit e c oncen t r ation s to
i nt e gra tive re a ction n e t w or k s . Int J Epid e mi ol. 2016 ;45(5) :1319– 28 .
13. Grund s t röm H, L ar sson B, Aren dt -Ni els en L , Gerdle B , Kj ølhede P . P ain cata s tr op h i z ing is
a ssocia t e d with p a in thr e s h old s f o r h e at, col d and pre s sure in wom en wi t h chroni c pelvi c
pa in. S cand J p ain. 20 20;20 (3):635 –46.
14. Jarr ell J , M alekzad eh L, Y ang H, Aren dt -N iels en L . The signi fican c e of c ut aneo us all odynia in a
w oman w ith chronic pel vic pain. J O bs t e t Gy naec ol C ana da . 2015 ;37(7 ):628– 32 .
15. L aurse n BS, Ba jaj P , O le sen A S , Delmar C, A ren d t -Niel se n L . Heal th rela t e d qu ali t y of lif e a nd
qu anti tative p ai n mea s ur emen t i n femal e s w ith chr onic non -mal ignant p a in. Eur J pa in.
20 05;9(3) :267– 75.
16. Ka ya S , Herman s L, Wil lem s T, Rou s s e l N , Meeu s M. Cen tral se nsi tiz a t i on in ur ogy necol ogic al
c hronic pelvic pai n: a sys t e ma tic lite ratu re r e view . P ain Phy sicia n . 2013 ;16(4 ):291 –3 08.
17. Grund s t röm H, G erdl e B, Ale hag en S, B erterö C, A r en d t -Niel se n L , Kjøl hede P . Red uce d pain
t h r es h ol ds a n d s i g n s of s e ns it i z at ion i n wo m e n w it h p e rs ist e n t pe l vi c pa i n a nd s usp e ct ed
e ndome trio s i s. Ac t a O b s te t Gynec ol Sc an d. 2 019;98(3 ):32 7–36 .
18. As s a rs s o n E, L undberg M, Holmq uist G , B jörke sten J , Bucht Tho rs en S, Ekma n D, e t al.
Homog enou s 96-pl ex PEA imm unoa s s ay exhi biting hi gh sen si t i vity, spec i fici t y , an d e xce llent
sca labili t y . PL oS One . 201 4;9(4 ):e9519 2 .
19. L ee MC, Zambr eanu L, Men o n DK, Trac ey I. Iden ti fying brain ac tivity s pec i fic ally r e l ated to th e
ma intena nc e and pe rcept ual con sequ en c e of c en tral sen si t i z a tion in huma n s . J N euro sci.
20 08;28(45) :11 642–9.
20. Wani ga seke ra V, Lee MC H , Roger s R , Hu P, Trac ey I . N e u r a l corr ela te s of a n injury-f ree mo d el
of cent ral sen si tiz a t io n induc ed by opioid w ithdrawal in huma n s . J N eu ro sci.
20 11;31(8) :283 5–42.
21. L ee MC, Plone r M, Wi ec h K, Bin gel U, Wa nig asek era V, Br o ok s J, e t al. Amy gdala a ctiv ity
c ontr i bu te s to the di ssoc ia tive e ffe ct o f c annabi s on pain p e r c ep tion. PA IN®.
20 13;154(1) :12 4–34.
22. Gwi lym S E, Kel t ne r JR , W a rna by CE, C arr A J, C hiz h B, Che s s e ll I , e t a l. P syc hophy sic a l and
func tio nal imaging evi dence s upp o r ting t he pre se nce of ce ntr al s en sitiza tion in a cohort o f
os teoa rth riti s pa t i en t s . Ar thri ti s C a r e R es O f f J Am Co ll R heuma t o l. 2009; 61 (9) :12 26–3 4.
23. Viton i s AF, Vinc e nt K, Rahmi og lu N, Fa ss bender A, Buc k L ouis GM , H u mmel shoj L, et al. W orld
E ndometrio s i s R e sea rc h Founda t i on End ome t rio si s Phenom e and bio ba nking har monization
proje ct: II. Cl inica l and cova r i ate p heno typ e data c oll ec tion in e ndome trio s i s r es ea rch. Fer til
S t e r i l . 2014; 102(5 ):1223– 32 .
24. F r e ynhag en R, B a r on R , Gocke l U, Töll e TR. Pa in DETECT : a new scre ening que sti o nnaire t o
i denti fy neu r op a t h ic c ompon ent s in pa t i e nts w ith bac k pai n. Cur r M e d R es O pi n.
20 06;22(10) :19 11–20.
25. Dwo r k in RH, Turk DC, Revic ki DA , Hardin g G , Coyne KS, P ei r c e -Sa n dner S , et a l . D e vel opment
a nd initia l val ida tion o f a n ex pand ed a nd revise d v er s ion o f the Sh ort -for m McGi ll Pa in
Qu e stionn aire (S F -MP Q-2 ). Pa in®. 2 009;1 44(1– 2) :35–42.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
26. Wolf e F, Häu se r W, Ha sse tt AL, Ka tz RS , Walit t BT. Th e dev el opment o f fibromy al gia –I:
e xamina tion o f ra te s and pr edi ct or s in pa tient s with rheuma t oi d ar thr i t i s (R A) . PA I N®.
20 11;152(2) :29 1–9.
27. Gei s ser M , Cla uw D, Grac ely R, Ambr ose K, Ly den A, Wil liams D. (396) S cre ening p ain and
fa t ig u e c onditio ns u s i ng t he C omp lex Me d ical Symptoms Inv e nto r y . J P ai n. 2008; 9 (4):75 .
28. Gonzal ez YM, S chif fma n E, G ordon S M, S eago B, Truel ov e EL , Sla de G, et al . Devel o pment o f a
brie f and e ff ec t i ve t emporoma ndibular d i s or der pai n s c r eening qu e st io nn aire : reli a bility a nd
v alidity . J Am D ent A ssoc . 2011;14 2(10 ): 1183– 91.
29. S vedlu nd J, Sjöd in I, Do teva ll G . GSRS —a c linic al rating s c ale for g a stroint e stin al sy mptoms in
pa t i en t s w ith irri t a bl e bow el synd rome a nd peptic ulc er di s ea se . Dig Di s Sc i. 198 8; 33(2):129 –
34 .
30. Z igmond AS , Sna ith R P. The ho spi tal anx i ety a nd dep re s s i on s c ale . Acta P syc hiatr Sc and.
19 83;67(6) :361 –70.
31. S pielbe r g e r C D . Ma nual for th e S t ate -Trai t Anxie t y Inve n t o r y STAI (fo rm Y)(“ se l f-e valua t i on
qu e s tionn a ire” ). 19 83;
32. S ulliv an MJL, B i s hop SR, Piv ik J. The pa in ca t a s t rophizing sca le : dev elopme nt a nd va lidation .
Psyc hol A s se ss . 1995;7 (4 ):524 .
33. John OP, Sriva st ava S. Th e Big -Fi ve trai t t ax onomy: Hist or y , mea sur emen t, a nd th eore tica l
pe rspec t i ves . V ol. 2. U ni ve r s i t y of Cali for nia Berkel e y; 199 9.
34. Rol ke R, Bar on R, Mai e r C al, T ölle TR , Tr eede R -D, Be ye r A, e t al . Q u a nti t a tive se nso ry te st i ng
i n the G erman R es earc h N e t w o r k on Neu ropathic Pain ( D F N S ) : standa r di z ed p r ot o c ol and
ref ere nc e va lue s. Pain . 2006;12 3(3) :231– 43 .
35. T u FF, Epste in AE, P ozolo K E, Se xton DL, Mel nyk A I , Hellma n KM . A non -inva s iv e b la dder
sen s ory te s t s up por ts a role for dy s meno r rhea incr ea sing bladd e r n oxiou s
me chano sen si tivity . Clin J P ain . 20 13;29( 10).
36. Ko s ek E, O rdeb erg G. L ack of p re ssur e pa i n modula t i on by he t e rotopi c nox iou s co nditio ning
stimul ation in p atie n ts wi t h pain ful o s t eo arthri ti s be fore , but n ot follow ing, surgic al pa in
reli e f. Pain . 2000;8 8 (1) :69–78.
37. S utclif fe S , Coldi tz GA , Goo dman MS, Pak pa han R, Ve tte r J, N e s s T J , e t al. U r ologi c al chronic
pe lvic pain s y ndr o m e sympt om flar e s: ch a r a ct eri sat ion o f the full rang e of f l ar e s a t t w o si te s
i n the Mul tidi scipl inary App roac h t o the S t ud y of C hronic P elv ic P ain ( MA PP ) Re se arc h
Netwo rk. BJU In t [In ter net ] . 20 14 Dec 1; 114(6):916 –25. Ava ilabl e f r o m:
http s: //doi. org/10 .111 1/ bj u.12778
38. Ke ller SD , Y ang M, T r e adwel l M J, W ern er EM, Hasse ll KL. P ati ent r epor ts of h e al th outco me
for a dul t s li ving with sick le c ell di s e a se: d evelop men t and te s ting of the AS C Q-Me i t e m bank s .
Hea lt h Q u a l Life Outc ome s. 2014;12 (1 ):1 –11.
39. Ce lla D, L ai J -S, Now inski C J, Vic tors on D, Pe te r ma n A , Mille r D, e t al. Neur o- QOL: brie f
me as u r e s o f he al th -r e l at ed qua lity o f li fe for clini cal r e sea r c h in n e ur ol ogy. Neur ol og y.
20 12;78(23) :18 60–7.
40. Pe nn ebak er JW , Su sman JR. Di sclo sure o f tra uma s and p s y chos omatic pr o c e sse s. S oc S ci
Med . 1988;2 6 (3) :327–32.
41. Nunez -Bad ine z P, De Leo B, La ux-Bi ehlm a nn A, Ho ffman n A, Zollner T M, Saunde rs PTK, e t al.
Prec linic al m od el s of endome trio si s and i nter s t i t i al c y s ti ti s/bl adder p ai n synd rome : an
In novativ e M edic ine s Ini tia tive -Pain Car e i nitiative t o improve t hei r value for t ran sl ationa l
re sea rch in pel vic pain. P ain. 20 21;
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Fig ur e s a nd Tables
Se e o ur ge n eral f or m at t in g guidel i ne s . Autho rs mu st limi t the n umb er of tabl e s a nd figure s i n th e
manu s c r ip t to 3 in or der to be con si s t ent w ith a note a rt i cle ty pe.
Addition a l ta ble s / fig ure s ca n b e pr ovide d a s add i t i onal file s or b e de po sit ed in a n ap pr op ria te d a ta
depo sito ry (e .g . Fig s h a r e ).
Figu re 1. S tu dy Desig n Fi g ure. Pha se I in Oxford a n d Bo s ton c o nducted p rio r to T R iP P c omme n cem e n t. P arti cipan ts from
Oxford an d Bo s ton s electe d ba se d o n inc lu s i o n cr it eria from a v a i labl e coho rts (E n d OX an d B C E ). P h as e I recruitment a t
Po rto (I BMC) c o m menced with stud y. P h a s e II in c l ud e d a d d it ional question naire s c o m p lete d o n li ne or on paper fo r all site s.
Ph ase II I c arri e d o u t by tr ain e d res e a rc h e r s a t eac h site . Ph ase I V carried ou t at Oxford b y tra i ned re search ers.
Additional Questionnaires
P h y s io lo g i c a l T e s t in g
fM RI ( onl y cond uct ed at O xf ord )
A d ditio nal Ques t i on naires
E A P, E A B P, B P S , P P, C o n
( s e le c t e d f r om E nd O X a n d BC E )
BPS
(recru it ed at I BMC)
Bas el in e Q u es t i on naires , Bl oo d,
Sali v a, U r in e (p r eviou s l y
co l l e c te d )
Phase II
Ph
ase I
II
Phase IV
Ph
ase I
Phase I and II
Baseli ne Ques tio nnai r es + Blo od,
Sali v a, Uri ne
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Table 1. TRiPP Study Measures and Outcomes.
Domain Tool Study Component Study
Phase
Pain:
• Cli n ic a l
his tor y of
pelv ic p a i n
EP He c t cli n ic al co v ari at e s q ue sti o nnai r e
(2 3)
Bas e li ne q ue s tion n a ire
Fo l lo w- up qu est ion na i re
I
II
• Int ens it y N R S Bas e li ne q ue s tion n a ire
Fo l lo w- up qu est ion na i re
How are you t od ay ?
I
II
III
• Nat ure i) pa i n DET ECT (2 4 )
ii) S h ort-f orm M c Gil l Pai n Quest io n naire 2
( S F M PQ 2) (2 5 )
P a in C ha r a c t e r i st i c s II
• Lo ca ti o n i) Fibr om yalgia s urv ey sc ale (2 6)
ii) Bod y m ap
O t he r sym pto m s a nd
experi ences
How are you t od ay ?
II
III
• Co mo r bi d
pain
c o n dit ion s
i) D iag n o s es gi v e n
ii) Co m pl ex m edic a l sym pt o m s in v e n t ory
(2 7)
iii) T M D -p a i n screen i n g t oo l ( 28)
Bas e li ne q ue s tion n a ire
Fo l lo w- up qu est ion na i re
O t he r sym pto m s a nd
experi ences
I
II
II
Gastr oin tes ti nal
sy mp t o ms
i) EP H ect c l i nical c ovariate s q u es t io nn a ire
(2 3)
ii) The G a s t roint es ti na l Sy mpt om Rati n g
Scale (2 9)
Bas e li ne q ue s tion n a ire
Fo l lo w- up qu est ion na i re
O t he r sym pto m s a nd
experi ences
I
II
Mo o d Hos p i tal Anxie ty a n d Depres si on Scal e
(HADS) ( 30)
O t he r sym pto m s a nd
experi ences
II
S t at e an x i e ty in v e n to ry ( 31 ) H o w a r e y o u to da y? III
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint
Pa i n C o g n i ti on s Pa i n C at astr o ph i s in g Scale ( 3 2) B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Ho w a re y o u t o d a y
I
II
III
Pe r so n a lit y Pe r so n a lit y I n v e n t ory ( 3 3 ) Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
Soma tos ens ory
proces si n g
i) Q ST ( 34) o n t he l ower abd o m e n (tes t
site) an d d ors um o f t he f oo t (c on trol s ite)
ii) f M RI wi t h p u nctat e s timu li o n t he t hig h
P hy si o log i ca l te s ti n g
fM RI
III
IV
Visceral s ens iti vit y Blad de r Sens iti vit y pa ra dig m (3 5) P h ys io l o g ic a l t est ing III
A u t o no m i c ne r v ou s
s y st em fun c t ion
i) heart ra t e mon it oring bef ore a n d aft er
p a in s ti m u li
P h ys io l o g ic a l t est ing III
HP A a x i s f u ncti o n i) 2 4 hour c ortis ol p r o fil e ( s a li va)
ii) c ort is ol bef o re an d a fter p a i n s ti m u li
(saliv a)
P h ys io l o g ic a l t est ing III
En d og enou s pa in
m o du la t ion
Co ndit ion ed pain m odu la t io n paradi gm
(3 6 )
P h ys io l o g ic a l t est ing III
Fl ares i n sy mpt o ms
and tri g g ers
Ch a racterist ic s o f fl are s i n s ym pt oms an d
ass ociat ed tri g g ers ( 37)
F la r e s qu es tion na i
r e II
Sl ee p a nd f atig ue i) AS CQ-Me v 2 Slee p I m pa c t S h o r t For m
(3 8 )
ii) N eur o-Q OL v1 F a t ig ue ( 3 9 )
Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
M e d i c a l h i s to r y i ) E P He c t c l in i ca l c ov a r ia t e s qu e st ion na i re
ii) All e r gies
B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
Oth e r s y mpt o ms a nd
ex pe r i e nc es
I
II
II
T r a u ma C h i ld ho od t r a um a ti c e ve nt s sc a l e (4 0 )
Rece n t tra u m at ic e v e nt s sc ale (4 0)
Oth e r s y mpt o ms a nd
ex pe r i e nc es
II
Tre a tm ents Tre a tm ents t ri e d qu esti o n s wi th s cori ng of
ou t c om e
T rea tme nts trie d
ques ti onn aire
II
Ove r a ll h ea l t h EPHect c linica l c ovari a t es q u e st io n na ire B as eline ques ti onn aire
F ol l o w -up quest io n n a ire
I
II
Tabl e 2 . S tudy P ar a di g m . Asses s m e n t-too ls employ ed at ea c h stud y ph ase ba se d o n t h e domains o f interest.
. CC-BY-NC-ND 4.0 International licenseIt is made available under a
is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted April 10, 2023. ; https://doi.org/10.1101/2022.05.16.22274828doi: medRxiv preprint